Facebook Linkedin Twitter
Inside Precision Medicine AstraZeneca’s Durvalumab Granted Priority Review for Form of Small Cell Lung Cancer

United States Food and Drug Administration

Lung cancer, close-up
News & Features

AstraZeneca’s Durvalumab Granted Priority Review for Form of Small Cell Lung Cancer

Chris Anderson -
0
Colon cancer. Cancer attacking cell. Colon disease concept
Molecular Dx

Guardant’s Liquid Biopsy Test for CRC Gets FDA Nod

Malorye Branca -
0
Sarcoma cells
News & Features

First Engineered T Cell Therapy for Solid Tumors Approved by the FDA

Chris Anderson -
0
x-ray lung cancer
News & Features

AI Warning on “Fairness Gaps” for X-Ray Analysis

Anita Chakraverty -
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Studies Address Risk for Secondary Cancers Related to CAR T Cell Therapy

Laura Cowen -
0
DNA molecular structure and data
News & Features

FDA’s Rare Disease START Program Selects Calico Drug, and Several More

Malorye Branca -
0
Julia Vitarello and her daughter Mila
News & Features

Building a Bridge Between Rare Disease Patients and the Technologies that Could Help Them

Kathy Vuksanaj -
0
Astronaut in the desert looking at the moon
Informatics

New Frontiers in CDx Development

Chris Anderson -
0
Image of gut and intestines showing colorectal cancer highlighted in red.
Molecular Dx

Geneoscopy’s RNA-Based Colorectal Cancer Test Approved by FDA

Helen Albert -
0
Close-up of Internal organs dummy on white background. Human anatomy model. Heart Anatomy Internal.
News & Features

Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA

Chris Anderson -
0
123...16Page 1 of 16

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine